 Amiodarone evaluation drug-induced toxicity Amiodarone antiarrhythmic drug class III effects serious adverse drug reactions interactions Pharmacy Cardiology monitoring parameters institution Criteria current literature Twenty-six patients amiodarone entry audit patients medical records unavailable incomplete eligible patients initiation therapy Outpatient Cardiology Clinic data medical charts following elements criteria baseline evaluation start therapy monitoring signs pulmonary hepatic thyroid cardiac ophthalmologic neurologic dermatologic toxicity evaluation potential drug interactions digoxin warfarin-type anticoagulants percentage criteria elements patient percent average percent overlooked parameters patient possible photosensitivity reaction digoxin dose patient amiodarone slit-lamp examination months Frequent examination patient total organ system laboratory tests addition patient education essential safe monitoring amiodarone therapy